Back to search
FDAFDA · Food and drugs·Recall number D-0621-2018

Conzerol zero molluscum contagiosum, Topical Cream, Net weight 0.78 (22g), Elrose Labs, Sanford Fl 32771 USA --- NDC 70223-001-06

Published April 18, 2018 · Recall initiated: March 28, 2018

Summary

FDA records drug Class II recall D-0621-2018, published April 18, 2018 and initiated March 28, 2018. Recalling firm: Elroselabs Inc.; Status: Terminated; Reported quantity: Unknown; Lot: All product within expiry. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

cGMP Deviations

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Elroselabs Inc.
Distributor
Nationwide.
Lot
All product within expiry
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Conzerol zero molluscum contagiosum, Topical Cream, Net weight 0.78 (22g), Elrose Labs, Sanford Fl 32771 USA --- NDC 70223-001-06 recalled?

Yes. FDA published recall D-0621-2018 on April 18, 2018. Reported hazard: cGMP Deviations

What should I do if I have this product?

Voluntary: Firm initiated · Letter